Back to search

Peptide record

TPDB06585

Antibacterial Anticancer Toxicity standard
12 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB06585
Antibacterial Anticancer Toxicity
Anti-infective peptides Cancer-related peptides Toxicity and safety peptides
AntiBP3 dbAMP DRAMP Peptipedia
standard
No
A 12-aa standard natural multi-activity (Antibacterial, Anticancer, and Toxicity) peptide sequence curated from AntiBP3, dbAMP, DRAMP, and other sources, with an available 3D structural model.
Sequence
KRIVKLIKKWLR
Physicochemical Analysis
C76H137N23O13
ANDCEQGHMFPSTY
K
1581.07
12.44
6
0
6
+6
2.06
-0.392
154.17
Mammalian: 1.3 hour Yeast: 3 min E.coli: 2 min
5500
347.87
0
Residue Composition
number
0
A
2
R
0
N
0
D
0
C
0
E
0
Q
0
G
0
H
2
I
2
L
4
K
0
M
0
F
0
P
0
S
0
T
1
W
0
Y
1
V
Amino Acid Distribution
A: 0 R: 2 N: 0 D: 0 C: 0 E: 0 Q: 0 G: 0 H: 0 I: 2 L: 2 K: 4 M: 0 F: 0 P: 0 S: 0 T: 0 W: 1 Y: 0 V: 1
Chemical Descriptors
12
C76H137N23O13
1581.07
12.44
+6
2.06
-0.392
Evidence Records 9 records
Evidence 1 Activity

Activity

MIC
Antibacterial
2 µM

Target

Escherichia coli KCTC 1682

Source & Reference

dbAMP DRAMP

Other

Source Activity Label Source Definition
Antibacterial
dbAMP classified as Antibacterial under the Anti-bacterial function class. DRAMP antibacterial activity supported by MIC records against bacterial target organisms.
active against Gram- E. coli KCTC 1682 (MIC 2 uM), P. aeruginosa KCTC 1637 (MIC 4 uM), S. typhimurium KCTC 1926 (MIC 1 uM), Gram+ B. subtil
Evidence 2 Activity

Activity

MIC
Antibacterial
4 µM

Target

Pseudomonas aeruginosa KCTC 1637

Source & Reference

dbAMP DRAMP

Other

active against Gram- E. coli KCTC 1682 (MIC 2 uM), P. aeruginosa KCTC 1637 (MIC 4 uM), S. typhimurium KCTC 1926 (MIC 1 uM), Gram+ B. subtilis KCTC 3068 (MIC 8 uM), S. epidermi
Evidence 3 Activity

Activity

MIC
Antibacterial
1 µM

Target

S. typhimurium KCTC 1926

Source & Reference

dbAMP DRAMP

Other

active against Gram- E. coli KCTC 1682 (MIC 2 uM), P. aeruginosa KCTC 1637 (MIC 4 uM), S. typhimurium KCTC 1926 (MIC 1 uM), Gram+ B. subtilis KCTC 3068 (MIC 8 uM), S. epidermidis KCTC 1917 (MIC 1 uM), and S. aure
Evidence 4 Activity

Activity

MIC
Antibacterial
8 µM

Target

B. subtilis KCTC 3068

Source & Reference

dbAMP DRAMP

Other

MIC 2 uM), P. aeruginosa KCTC 1637 (MIC 4 uM), S. typhimurium KCTC 1926 (MIC 1 uM), Gram+ B. subtilis KCTC 3068 (MIC 8 uM), S. epidermidis KCTC 1917 (MIC 1 uM), and S. aureus KCTC 1621 (MIC 2 uM). Warning: Nonsta
Evidence 5 Activity

Activity

MIC
Antibacterial
1 µM

Target

Staphylococcus epidermidis KCTC 1917

Source & Reference

dbAMP DRAMP

Other

(MIC 4 uM), S. typhimurium KCTC 1926 (MIC 1 uM), Gram+ B. subtilis KCTC 3068 (MIC 8 uM), S. epidermidis KCTC 1917 (MIC 1 uM), and S. aureus KCTC 1621 (MIC 2 uM). Warning: Nonstandard assays. The peptide can also bi
Evidence 6 Activity

Activity

MIC
Antibacterial
2 µM

Target

Staphylococcus aureus KCTC 1621

Source & Reference

dbAMP DRAMP

Other

C 1 uM), Gram+ B. subtilis KCTC 3068 (MIC 8 uM), S. epidermidis KCTC 1917 (MIC 1 uM), and S. aureus KCTC 1621 (MIC 2 uM). Warning: Nonstandard assays. The peptide can also bind to LPS and show an anti-inflammat
Evidence 7 Activity

Activity

50% Hemolysis
Toxicity
>800 µM
Hemolytic Cytotoxic
50% Hemolysis | >800 | µM | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Short KR-12 analogs designed from human cathelicidin LL-37 possessing both antimicrobial and antiendotoxic activities without mammalian cell toxicity. | J Pept Sci | 2013
Evidence 8 Activity

Activity

10% Hemolysis
Toxicity
>128 µM
Hemolytic Cytotoxic
10% Hemolysis | >128 | µM | target cell: Sheep erythrocytes

Target

Sheep erythrocytes

Source & Reference

NA
DBAASP
A novel hybrid peptide composed of LfcinB6 and KR-12-a4 with enhanced antimicrobial, anti-inflammatory and anti-biofilm activities. | Sci Rep | 2022
Evidence 9 Activity

Activity

HC50
Toxicity
800 µM
Hemolytic Cytotoxic
Hemolytic_activity: [Ref.24105706] HC50>800 µM against human red blood cells | Cytotoxicity: [Ref.24105706] The cell viability of RAW264.7 macrophage cells is 101.9%, 99.9%, 96.6%, 95.6%, 95.3%, 80.9%, 17.8% and 0% at peptide concentrations of 0.78, 1.56, 3.12, 6.25, 12.5, 25, 50 and 100 µM.

Target

erythrocytes

Source & Reference

NA
DRAMP
J Pept Sci. 2013 Nov 19(11):700-7. doi: 10.1002/psc.2552.